Terlipressin with Limited Fluid Resuscitation in a Swine Model of Hemorrhage
Abstract Background Principles of damage control resuscitation include minimizing intravenous fluid (IVF) administration while correcting perfusion pressure as quickly as possible. Recent studies have identified a potential advantage of vasopressin over catecholamines in traumatic shock. Terlipressi...
Gespeichert in:
Veröffentlicht in: | The Journal of emergency medicine 2013-07, Vol.45 (1), p.78-85 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 85 |
---|---|
container_issue | 1 |
container_start_page | 78 |
container_title | The Journal of emergency medicine |
container_volume | 45 |
creator | Devlin, John J., MD, CDR, MC, USN DeVito, Sara S., BS, LATG Littlejohn, Lanny F., MD, CDR, MC, USN Gutierrez, Miguel A., MD, CDR, MC, USN Nowak, Gosia, MSC, MPH Henao, José, MD, CDR, USN Bielawski, Anthony, MD, CDR, USN Kotora, Joseph, DO, CDR, USN Johnson, Andrew S., MD, CAPT, MC, USN |
description | Abstract Background Principles of damage control resuscitation include minimizing intravenous fluid (IVF) administration while correcting perfusion pressure as quickly as possible. Recent studies have identified a potential advantage of vasopressin over catecholamines in traumatic shock. Terlipressin (TP) is a vasopressin analogue used to reverse certain shock etiologies in some European countries. Study Objective We evaluated three dosages of TP when combined with a limited colloid resuscitation strategy on mean arterial pressure (MAP) and lactatemia in a swine model of isolated hemorrhage. Methods Sixty anesthetized swine underwent intubation and severe hemorrhage. Subjects were randomized to one of four resuscitation groups: 4 mL/kg Hextend® (Hospira Inc, Lake Forest, IL) only, 3.75 μg/kg TP + Hextend, 7.5 μg/kg TP + Hextend, or 15 μg/kg TP + Hextend. MAP and heart rate were recorded every 5 min. Baseline and serial lactate values at 30-min intervals were recorded and compared. Results Subjects receiving 7.5 μg/kg TP had significantly higher MAPs at times t15 ( p = 0.012), t20 ( p = 0.004), t25 ( p = 0.018), t30 ( p = 0.032), t35 ( p = 0.030), and t40 ( p = 0.021). No statistically significant differences in lactate values between TP groups and controls were observed. Conclusion Subjects receiving 7.5 μg/kg of TP demonstrated improved MAP within 10 min of administration. When combined with minimal IVF resuscitation, TP doses between 3.75 and 15 μg/kg do not elevate lactate levels in hemorrhaged swine. |
doi_str_mv | 10.1016/j.jemermed.2012.12.023 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1373437955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0736467912017295</els_id><sourcerecordid>1373437955</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-f4948edca2ef0064bc7e35a5f2f36974e1ecdeacd7d911a0dee6a9773f222a1d3</originalsourceid><addsrcrecordid>eNqFkU1OwzAQhS0EoqVwhSpLNin-S0w2CISAIrVC4mdtufYEHJK42AmI23AWToaj0g0bpJFmMe-90XyD0JTgGcEkP6lmFTTgGzAzigmdxcKU7aAxZRlNM0yLXTTGguUpz0UxQgchVBgTgU_JPhpRlmNKOB-j5SP42q49hGDb5MN2L8nCNrYDk1zXvTXJPYQ-aNupzro2iRqVPHzYFpKlM1Anrvz-mkPjvH9Rz3CI9kpVBzj67RP0dH31eDlPF3c3t5cXi1Rzyrq05AU_BaMVhRLjnK-0AJaprKQlywvBgYA2oLQRpiBEYQOQq0IIVlJKFTFsgo43uWvv3noInWxs0FDXqgXXB0mYYJyJIsuiNN9ItXcheCjl2ttG-U9JsBxQykpuUcoBpYwVUUbj9HdHvxpmW9uWXRScbwQQL3234GXkBK0GYz3oThpn_99x9idC17a1WtWv8Amhcr1vI0dJZIgG-TA8dPgniSGCFhn7AZNznr4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1373437955</pqid></control><display><type>article</type><title>Terlipressin with Limited Fluid Resuscitation in a Swine Model of Hemorrhage</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Devlin, John J., MD, CDR, MC, USN ; DeVito, Sara S., BS, LATG ; Littlejohn, Lanny F., MD, CDR, MC, USN ; Gutierrez, Miguel A., MD, CDR, MC, USN ; Nowak, Gosia, MSC, MPH ; Henao, José, MD, CDR, USN ; Bielawski, Anthony, MD, CDR, USN ; Kotora, Joseph, DO, CDR, USN ; Johnson, Andrew S., MD, CAPT, MC, USN</creator><creatorcontrib>Devlin, John J., MD, CDR, MC, USN ; DeVito, Sara S., BS, LATG ; Littlejohn, Lanny F., MD, CDR, MC, USN ; Gutierrez, Miguel A., MD, CDR, MC, USN ; Nowak, Gosia, MSC, MPH ; Henao, José, MD, CDR, USN ; Bielawski, Anthony, MD, CDR, USN ; Kotora, Joseph, DO, CDR, USN ; Johnson, Andrew S., MD, CAPT, MC, USN</creatorcontrib><description>Abstract Background Principles of damage control resuscitation include minimizing intravenous fluid (IVF) administration while correcting perfusion pressure as quickly as possible. Recent studies have identified a potential advantage of vasopressin over catecholamines in traumatic shock. Terlipressin (TP) is a vasopressin analogue used to reverse certain shock etiologies in some European countries. Study Objective We evaluated three dosages of TP when combined with a limited colloid resuscitation strategy on mean arterial pressure (MAP) and lactatemia in a swine model of isolated hemorrhage. Methods Sixty anesthetized swine underwent intubation and severe hemorrhage. Subjects were randomized to one of four resuscitation groups: 4 mL/kg Hextend® (Hospira Inc, Lake Forest, IL) only, 3.75 μg/kg TP + Hextend, 7.5 μg/kg TP + Hextend, or 15 μg/kg TP + Hextend. MAP and heart rate were recorded every 5 min. Baseline and serial lactate values at 30-min intervals were recorded and compared. Results Subjects receiving 7.5 μg/kg TP had significantly higher MAPs at times t15 ( p = 0.012), t20 ( p = 0.004), t25 ( p = 0.018), t30 ( p = 0.032), t35 ( p = 0.030), and t40 ( p = 0.021). No statistically significant differences in lactate values between TP groups and controls were observed. Conclusion Subjects receiving 7.5 μg/kg of TP demonstrated improved MAP within 10 min of administration. When combined with minimal IVF resuscitation, TP doses between 3.75 and 15 μg/kg do not elevate lactate levels in hemorrhaged swine.</description><identifier>ISSN: 0736-4679</identifier><identifier>EISSN: 2352-5029</identifier><identifier>DOI: 10.1016/j.jemermed.2012.12.023</identifier><identifier>PMID: 23602144</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Arterial Pressure - drug effects ; damage control ; Disease Models, Animal ; Emergency ; Fluid Therapy ; Heart Rate - drug effects ; hemorrhage ; Hemorrhage - drug therapy ; Hemorrhage - therapy ; Lactic Acid - blood ; Lypressin - administration & dosage ; Lypressin - analogs & derivatives ; military ; resuscitation ; shock ; Swine ; terlipressin ; Vasoconstrictor Agents - administration & dosage</subject><ispartof>The Journal of emergency medicine, 2013-07, Vol.45 (1), p.78-85</ispartof><rights>2013</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-f4948edca2ef0064bc7e35a5f2f36974e1ecdeacd7d911a0dee6a9773f222a1d3</citedby><cites>FETCH-LOGICAL-c423t-f4948edca2ef0064bc7e35a5f2f36974e1ecdeacd7d911a0dee6a9773f222a1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jemermed.2012.12.023$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23602144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Devlin, John J., MD, CDR, MC, USN</creatorcontrib><creatorcontrib>DeVito, Sara S., BS, LATG</creatorcontrib><creatorcontrib>Littlejohn, Lanny F., MD, CDR, MC, USN</creatorcontrib><creatorcontrib>Gutierrez, Miguel A., MD, CDR, MC, USN</creatorcontrib><creatorcontrib>Nowak, Gosia, MSC, MPH</creatorcontrib><creatorcontrib>Henao, José, MD, CDR, USN</creatorcontrib><creatorcontrib>Bielawski, Anthony, MD, CDR, USN</creatorcontrib><creatorcontrib>Kotora, Joseph, DO, CDR, USN</creatorcontrib><creatorcontrib>Johnson, Andrew S., MD, CAPT, MC, USN</creatorcontrib><title>Terlipressin with Limited Fluid Resuscitation in a Swine Model of Hemorrhage</title><title>The Journal of emergency medicine</title><addtitle>J Emerg Med</addtitle><description>Abstract Background Principles of damage control resuscitation include minimizing intravenous fluid (IVF) administration while correcting perfusion pressure as quickly as possible. Recent studies have identified a potential advantage of vasopressin over catecholamines in traumatic shock. Terlipressin (TP) is a vasopressin analogue used to reverse certain shock etiologies in some European countries. Study Objective We evaluated three dosages of TP when combined with a limited colloid resuscitation strategy on mean arterial pressure (MAP) and lactatemia in a swine model of isolated hemorrhage. Methods Sixty anesthetized swine underwent intubation and severe hemorrhage. Subjects were randomized to one of four resuscitation groups: 4 mL/kg Hextend® (Hospira Inc, Lake Forest, IL) only, 3.75 μg/kg TP + Hextend, 7.5 μg/kg TP + Hextend, or 15 μg/kg TP + Hextend. MAP and heart rate were recorded every 5 min. Baseline and serial lactate values at 30-min intervals were recorded and compared. Results Subjects receiving 7.5 μg/kg TP had significantly higher MAPs at times t15 ( p = 0.012), t20 ( p = 0.004), t25 ( p = 0.018), t30 ( p = 0.032), t35 ( p = 0.030), and t40 ( p = 0.021). No statistically significant differences in lactate values between TP groups and controls were observed. Conclusion Subjects receiving 7.5 μg/kg of TP demonstrated improved MAP within 10 min of administration. When combined with minimal IVF resuscitation, TP doses between 3.75 and 15 μg/kg do not elevate lactate levels in hemorrhaged swine.</description><subject>Animals</subject><subject>Arterial Pressure - drug effects</subject><subject>damage control</subject><subject>Disease Models, Animal</subject><subject>Emergency</subject><subject>Fluid Therapy</subject><subject>Heart Rate - drug effects</subject><subject>hemorrhage</subject><subject>Hemorrhage - drug therapy</subject><subject>Hemorrhage - therapy</subject><subject>Lactic Acid - blood</subject><subject>Lypressin - administration & dosage</subject><subject>Lypressin - analogs & derivatives</subject><subject>military</subject><subject>resuscitation</subject><subject>shock</subject><subject>Swine</subject><subject>terlipressin</subject><subject>Vasoconstrictor Agents - administration & dosage</subject><issn>0736-4679</issn><issn>2352-5029</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1OwzAQhS0EoqVwhSpLNin-S0w2CISAIrVC4mdtufYEHJK42AmI23AWToaj0g0bpJFmMe-90XyD0JTgGcEkP6lmFTTgGzAzigmdxcKU7aAxZRlNM0yLXTTGguUpz0UxQgchVBgTgU_JPhpRlmNKOB-j5SP42q49hGDb5MN2L8nCNrYDk1zXvTXJPYQ-aNupzro2iRqVPHzYFpKlM1Anrvz-mkPjvH9Rz3CI9kpVBzj67RP0dH31eDlPF3c3t5cXi1Rzyrq05AU_BaMVhRLjnK-0AJaprKQlywvBgYA2oLQRpiBEYQOQq0IIVlJKFTFsgo43uWvv3noInWxs0FDXqgXXB0mYYJyJIsuiNN9ItXcheCjl2ttG-U9JsBxQykpuUcoBpYwVUUbj9HdHvxpmW9uWXRScbwQQL3234GXkBK0GYz3oThpn_99x9idC17a1WtWv8Amhcr1vI0dJZIgG-TA8dPgniSGCFhn7AZNznr4</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Devlin, John J., MD, CDR, MC, USN</creator><creator>DeVito, Sara S., BS, LATG</creator><creator>Littlejohn, Lanny F., MD, CDR, MC, USN</creator><creator>Gutierrez, Miguel A., MD, CDR, MC, USN</creator><creator>Nowak, Gosia, MSC, MPH</creator><creator>Henao, José, MD, CDR, USN</creator><creator>Bielawski, Anthony, MD, CDR, USN</creator><creator>Kotora, Joseph, DO, CDR, USN</creator><creator>Johnson, Andrew S., MD, CAPT, MC, USN</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130701</creationdate><title>Terlipressin with Limited Fluid Resuscitation in a Swine Model of Hemorrhage</title><author>Devlin, John J., MD, CDR, MC, USN ; DeVito, Sara S., BS, LATG ; Littlejohn, Lanny F., MD, CDR, MC, USN ; Gutierrez, Miguel A., MD, CDR, MC, USN ; Nowak, Gosia, MSC, MPH ; Henao, José, MD, CDR, USN ; Bielawski, Anthony, MD, CDR, USN ; Kotora, Joseph, DO, CDR, USN ; Johnson, Andrew S., MD, CAPT, MC, USN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-f4948edca2ef0064bc7e35a5f2f36974e1ecdeacd7d911a0dee6a9773f222a1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Arterial Pressure - drug effects</topic><topic>damage control</topic><topic>Disease Models, Animal</topic><topic>Emergency</topic><topic>Fluid Therapy</topic><topic>Heart Rate - drug effects</topic><topic>hemorrhage</topic><topic>Hemorrhage - drug therapy</topic><topic>Hemorrhage - therapy</topic><topic>Lactic Acid - blood</topic><topic>Lypressin - administration & dosage</topic><topic>Lypressin - analogs & derivatives</topic><topic>military</topic><topic>resuscitation</topic><topic>shock</topic><topic>Swine</topic><topic>terlipressin</topic><topic>Vasoconstrictor Agents - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Devlin, John J., MD, CDR, MC, USN</creatorcontrib><creatorcontrib>DeVito, Sara S., BS, LATG</creatorcontrib><creatorcontrib>Littlejohn, Lanny F., MD, CDR, MC, USN</creatorcontrib><creatorcontrib>Gutierrez, Miguel A., MD, CDR, MC, USN</creatorcontrib><creatorcontrib>Nowak, Gosia, MSC, MPH</creatorcontrib><creatorcontrib>Henao, José, MD, CDR, USN</creatorcontrib><creatorcontrib>Bielawski, Anthony, MD, CDR, USN</creatorcontrib><creatorcontrib>Kotora, Joseph, DO, CDR, USN</creatorcontrib><creatorcontrib>Johnson, Andrew S., MD, CAPT, MC, USN</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Devlin, John J., MD, CDR, MC, USN</au><au>DeVito, Sara S., BS, LATG</au><au>Littlejohn, Lanny F., MD, CDR, MC, USN</au><au>Gutierrez, Miguel A., MD, CDR, MC, USN</au><au>Nowak, Gosia, MSC, MPH</au><au>Henao, José, MD, CDR, USN</au><au>Bielawski, Anthony, MD, CDR, USN</au><au>Kotora, Joseph, DO, CDR, USN</au><au>Johnson, Andrew S., MD, CAPT, MC, USN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Terlipressin with Limited Fluid Resuscitation in a Swine Model of Hemorrhage</atitle><jtitle>The Journal of emergency medicine</jtitle><addtitle>J Emerg Med</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>45</volume><issue>1</issue><spage>78</spage><epage>85</epage><pages>78-85</pages><issn>0736-4679</issn><eissn>2352-5029</eissn><abstract>Abstract Background Principles of damage control resuscitation include minimizing intravenous fluid (IVF) administration while correcting perfusion pressure as quickly as possible. Recent studies have identified a potential advantage of vasopressin over catecholamines in traumatic shock. Terlipressin (TP) is a vasopressin analogue used to reverse certain shock etiologies in some European countries. Study Objective We evaluated three dosages of TP when combined with a limited colloid resuscitation strategy on mean arterial pressure (MAP) and lactatemia in a swine model of isolated hemorrhage. Methods Sixty anesthetized swine underwent intubation and severe hemorrhage. Subjects were randomized to one of four resuscitation groups: 4 mL/kg Hextend® (Hospira Inc, Lake Forest, IL) only, 3.75 μg/kg TP + Hextend, 7.5 μg/kg TP + Hextend, or 15 μg/kg TP + Hextend. MAP and heart rate were recorded every 5 min. Baseline and serial lactate values at 30-min intervals were recorded and compared. Results Subjects receiving 7.5 μg/kg TP had significantly higher MAPs at times t15 ( p = 0.012), t20 ( p = 0.004), t25 ( p = 0.018), t30 ( p = 0.032), t35 ( p = 0.030), and t40 ( p = 0.021). No statistically significant differences in lactate values between TP groups and controls were observed. Conclusion Subjects receiving 7.5 μg/kg of TP demonstrated improved MAP within 10 min of administration. When combined with minimal IVF resuscitation, TP doses between 3.75 and 15 μg/kg do not elevate lactate levels in hemorrhaged swine.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23602144</pmid><doi>10.1016/j.jemermed.2012.12.023</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0736-4679 |
ispartof | The Journal of emergency medicine, 2013-07, Vol.45 (1), p.78-85 |
issn | 0736-4679 2352-5029 |
language | eng |
recordid | cdi_proquest_miscellaneous_1373437955 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Animals Arterial Pressure - drug effects damage control Disease Models, Animal Emergency Fluid Therapy Heart Rate - drug effects hemorrhage Hemorrhage - drug therapy Hemorrhage - therapy Lactic Acid - blood Lypressin - administration & dosage Lypressin - analogs & derivatives military resuscitation shock Swine terlipressin Vasoconstrictor Agents - administration & dosage |
title | Terlipressin with Limited Fluid Resuscitation in a Swine Model of Hemorrhage |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T10%3A19%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Terlipressin%20with%20Limited%20Fluid%20Resuscitation%20in%20a%20Swine%20Model%20of%C2%A0Hemorrhage&rft.jtitle=The%20Journal%20of%20emergency%20medicine&rft.au=Devlin,%20John%20J.,%20MD,%20CDR,%20MC,%20USN&rft.date=2013-07-01&rft.volume=45&rft.issue=1&rft.spage=78&rft.epage=85&rft.pages=78-85&rft.issn=0736-4679&rft.eissn=2352-5029&rft_id=info:doi/10.1016/j.jemermed.2012.12.023&rft_dat=%3Cproquest_cross%3E1373437955%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1373437955&rft_id=info:pmid/23602144&rft_els_id=1_s2_0_S0736467912017295&rfr_iscdi=true |